Edgewise Therapeutics Inc
(EWTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,666 | 86,097 | 21,993 | 15,566 | 104,916 |
| Marketable Securities | 428,504 | 232,296 | 329,954 | 265,223 | 24,178 |
| TOTAL | $475,483 | $326,997 | $356,999 | $283,773 | $129,645 |
| Non-Current Assets | |||||
| PPE Net | 9,503 | 10,443 | 8,533 | 912 | 516 |
| Other Non-Current Assets | 1,831 | 2,595 | 1,569 | 548 | 975 |
| TOTAL | $11,334 | $13,038 | $10,102 | $1,460 | $1,491 |
| Total Assets | $486,817 | $340,035 | $367,101 | $285,233 | $131,136 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,579 | 4,025 | 6,105 | 3,843 | 1,580 |
| TOTAL | $23,860 | $16,771 | $16,585 | $10,521 | $4,342 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,741 | 4,434 | 3,800 | 329 | 0 |
| TOTAL | $3,741 | $4,434 | $3,800 | $329 | $N/A |
| Total Liabilities | $27,601 | $21,205 | $20,385 | $10,850 | $4,342 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 95,205 | 93,111 | 63,262 | 49,512 | N/A |
| Common Shares | 9 | 7 | 6 | 5 | N/A |
| Retained earnings | -378,576 | -244,763 | -144,600 | -76,960 | -34,147 |
| Other shareholders' equity | 420 | 99 | -1,355 | -514 | 160,214 |
| TOTAL | $459,216 | $318,830 | $346,716 | $274,383 | $126,794 |
| Total Liabilities And Equity | $486,817 | $340,035 | $367,101 | $285,233 | $131,136 |